Skip to main content
Clinical Trials/EUCTR2015-000456-15-GB
EUCTR2015-000456-15-GB
Active, not recruiting
Not Applicable

The prevention of pre-term birth in women who develop a short cervix. A multi-centre randomised controlled trial to compare three treatments; cervical cerclage, cervical pessary and vaginal progesterone. - SuPPoRT: Stitch,Progesterone or Pessary: a randomised controlled trial

Kings College London0 sitesMarch 11, 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Short Cervix in Pregnancy
Sponsor
Kings College London
Status
Active, not recruiting
Last Updated
10 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 11, 2015
End Date
TBD
Last Updated
10 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
Female

Investigators

Sponsor
Kings College London

Eligibility Criteria

Inclusion Criteria

  • Women with singleton pregnancies who are found to have cervical length \<25 mm on transvaginal ultrasound between 14\+0 weeks’ gestation (dated by ultrasound or LMP and adjusted for ultrasound estimated date of delivery once ultrasound performed if no miscarriage prior to dating ultrasound) until 23\+6 weeks’ gestation and one or more of the following risk factors;
  • Written informed consent to participate
  • History of
  • oPrevious preterm premature rupture of the fetal membranes (\= 37 weeks’)
  • oHistory of previous PTB/second trimester loss (\= 16 weeks’ or \= 37 weeks’ gestation).
  • oAny cervical procedure to treat abnormal smears i.e. large loop excision, laser conisation, cold knife conisation or radical diathermy.
  • Incidental finding of a short cervix on ultrasound scan (e.g. at the time of anomaly scan).
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1\.2 Adults (18\-64 years) yes

Exclusion Criteria

  • Women with persistent fresh vaginal bleeding evident on speculum examination.
  • Women with visible membranes evident on speculum examination or open cervix on ultrasound scan.
  • Women with severe abdominal pain/evidence of sepsis (as judged by attending clinician).
  • Known significant congenital or structural or chromosomal fetal abnormality.
  • Suspected or proven rupture of the fetal membranes at the time of recruitment.
  • Women currently using progesterone pessaries or who have taken progesterone beyond 18 weeks gestation.
  • Women who have a cervical suture in situ.
  • Women who already have a cervical pessary in situ.
  • Insufficiuent uUnderstanding of the tTrial in the opinion of the Investigator
  • Any contraindications or cautions to the investigational medicinal product including:

Outcomes

Primary Outcomes

Not specified

Similar Trials